Lewis JS - Search Results

1

ImmunoPET for mesothelin positive tissues using bio-orthogonal in-vivo click chemistry.

Pratt EC, Mandleywala K, Bauer D, Bolaender A, Chao G, Castanares MA, Collins EC, Lewis JS. Pratt EC, et al. Among authors: lewis js. Nucl Med Biol. 2025 Sep-Oct;148-149:109051. doi: 10.1016/j.nucmedbio.2025.109051. Epub 2025 Jul 15. Nucl Med Biol. 2025. PMID: 40694891

2

Pretargeted Trop-2 ImmunoPET for Rapid, Selective Detection of Pancreatic Tumors.

Pratt EC, Mandleywala K, Bauer D, Bolaender A, Chao G, Castanares MA, Collins EC, Lewis JS. Pratt EC, et al. Among authors: lewis js. Clin Cancer Res. 2025 Jul 1;31(13):2719-2726. doi: 10.1158/1078-0432.CCR-24-3098. Clin Cancer Res. 2025. PMID: 39841860

3

Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors.

Pereira PMR, Mandleywala K, Ragupathi A, Carter LM, Goos JACM, Janjigian YY, Lewis JS. Pereira PMR, et al. Among authors: lewis js. J Nucl Med. 2019 Nov;60(11):1569-1578. doi: 10.2967/jnumed.119.225813. Epub 2019 Jun 6. J Nucl Med. 2019. PMID: 31171598 Free PMC article.

4

EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder Tumors.

Hoang TT, Mandleywala K, Viray T, Tan KV, Lewis JS, Pereira PMR. Hoang TT, et al. Among authors: lewis js. Mol Imaging Biol. 2022 Aug;24(4):511-518. doi: 10.1007/s11307-022-01708-2. Epub 2022 Feb 11. Mol Imaging Biol. 2022. PMID: 35147837 Free PMC article.

5

Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer.

Mack KN, Samuels ZV, Carter LM, Viray TD, Mandleywala K, Brooks CL, Hollingsworth MA, Radhakrishnan P, Lewis JS. Mack KN, et al. Among authors: lewis js. J Nucl Med. 2024 Apr 1;65(4):580-585. doi: 10.2967/jnumed.123.266524. J Nucl Med. 2024. PMID: 38485271 Free PMC article.

6

Exploring the PET in vivo generator ¹³⁴Ce as a theranostic match for ²²⁵Ac.

Bauer D, De Gregorio R, Pratt EC, Bell A, Michel A, Lewis JS. Bauer D, et al. Among authors: lewis js. bioRxiv [Preprint]. 2024 Apr 28:2024.04.25.591165. doi: 10.1101/2024.04.25.591165. bioRxiv. 2024. Update in: Eur J Nucl Med Mol Imaging. 2024 Nov;51(13):4015-4025. doi: 10.1007/s00259-024-06811-w. PMID: 38712285 Free PMC article. Updated. Preprint.

7

Examination of the PET in vivo generator ¹³⁴Ce as a theranostic match for ²²⁵Ac.

Bauer D, De Gregorio R, Pratt EC, Bell A, Michel A, Lewis JS. Bauer D, et al. Among authors: lewis js. Eur J Nucl Med Mol Imaging. 2024 Nov;51(13):4015-4025. doi: 10.1007/s00259-024-06811-w. Epub 2024 Jun 28. Eur J Nucl Med Mol Imaging. 2024. PMID: 38940841 Free PMC article.

8

[⁸⁹Zr]ZrCl₄ for direct radiolabeling of DOTA-based precursors.

Lyashchenko SK, Tran T, Happel S, Park H, Bauer D, Jones K, Esposito TV, Pillarsetty N, Lewis JS. Lyashchenko SK, et al. Among authors: lewis js. Nucl Med Biol. 2024 Sep-Oct;136-137:108943. doi: 10.1016/j.nucmedbio.2024.108943. Epub 2024 Jul 26. Nucl Med Biol. 2024. PMID: 39094425 Free PMC article.

9

uPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence.

Pratt EC, Mezzadra R, Kulick A, Kaminsky S, Samuels ZV, Loor A, de Stanchina E, Lowe SW, Lewis JS. Pratt EC, et al. Among authors: lewis js. J Nucl Med. 2024 Nov 1;65(11):1718-1723. doi: 10.2967/jnumed.124.268278. J Nucl Med. 2024. PMID: 39362768 Free PMC article.

10

Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancer.

Mack KN, Bauer D, Carter LM, Carrasco SE, Atmane MI, Viray TD, Brooks CL, Hollingsworth MA, Radhakrishnan P, Lewis JS. Mack KN, et al. Among authors: lewis js. Nucl Med Biol. 2025 Jan-Feb;140-141:108976. doi: 10.1016/j.nucmedbio.2024.108976. Epub 2024 Nov 22. Nucl Med Biol. 2025. PMID: 39615062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,051 results

Search Page

Filters